Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06092970 · ClinicalTrials.gov registry record
An Evaluation of Patient Reported Outcomes and Clinical Outcomes
A clinical trial of Post-Operative Complications in Cardiac Surgery, sponsored by Renibus Therapeutics.
- Active
- Registry status
- 379
- Enrollment target
- 20
- Study locations
NCT06092970 is a study of Post-Operative Complications in Cardiac Surgery that is active but no longer recruiting, run by Renibus Therapeutics. The registered enrollment target is 379 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT06092970, a study of Post-Operative Complications in Cardiac Surgery, is active but no longer recruiting, sponsored by Renibus Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 379 participants
- Enrollment target
- 20
- Study locations
Study Summary
This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D questionnaire * Clinical outcomes
Conditions Studied
Interventions
- DRUG Placebo
- DRUG RBT-1
Study Locations (20)
Michigan
- Research Site - Ann Arbor
- Research Site - Lansing
- Research Site - Midland
- Research Site - Royal Oak
Indiana
- Research Site - Fort Wayne
- Research Site - Indianapolis
- Research Site - Indianapolis
California
- Research Site - San Francisco
- Research Site - Stanford
Florida
- Research Site - Atlantis
- Research Site - Gainesville
Georgia
- Research Site - Athens
- Research Site - Atlanta
Alabama
- Research Site - Huntsville
District of Columbia
- Research Site - Washington D.C.
Kansas
- Research Site - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2023-10-16 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06092970
The ClinicalTrials.gov registry entry for NCT06092970 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 379 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Renibus Therapeutics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-Operative Complications in Cardiac Surgery appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06092970 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Michigan, Indiana, California.
Frequently Asked Questions
What is clinical trial NCT06092970 about?
NCT06092970 is a clinical study titled "An Evaluation of Patient Reported Outcomes and Clinical Outcomes". This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D questionnaire * Clinical outcomes
What is the current status of trial NCT06092970?
This trial is currently active not recruiting. The enrollment target is 379 participants. The study started on 2023-10-16. Estimated completion is 2026-06-30.
What conditions does trial NCT06092970 study?
This clinical trial studies the following conditions: Post-Operative Complications in Cardiac Surgery.
What interventions are being tested in trial NCT06092970?
The interventions under investigation include: Placebo (DRUG), RBT-1 (DRUG).
Who is sponsoring clinical trial NCT06092970?
This trial is sponsored by Renibus Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06092970 being conducted?
This trial has 20 study locations across Alabama, California, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.